135 related articles for article (PubMed ID: 24685409)
1. Control of data quality for population-based cancer survival analysis.
Li R; Abela L; Moore J; Woods LM; Nur U; Rachet B; Allemani C; Coleman MP
Cancer Epidemiol; 2014 Jun; 38(3):314-20. PubMed ID: 24685409
[TBL] [Abstract][Full Text] [Related]
2. Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates.
Møller H; Richards S; Hanchett N; Riaz SP; Lüchtenborg M; Holmberg L; Robinson D
Br J Cancer; 2011 Jun; 105(1):170-6. PubMed ID: 21559016
[TBL] [Abstract][Full Text] [Related]
3. Are survival rates for Tyrol published in the Eurocare studies biased?
Oberaigner W; Siebert U
Acta Oncol; 2009; 48(7):984-91. PubMed ID: 19714522
[TBL] [Abstract][Full Text] [Related]
4. Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal.
Crocker-Buque T; Pollock AM
J R Soc Med; 2015 Feb; 108(2):57-67. PubMed ID: 25721114
[TBL] [Abstract][Full Text] [Related]
5. Renal replacement therapy registries--time for a structured data quality evaluation programme.
Couchoud C; Lassalle M; Cornet R; Jager KJ
Nephrol Dial Transplant; 2013 Sep; 28(9):2215-20. PubMed ID: 23386707
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.
Silva A; Rauscher GH; Ferrans CE; Hoskins K; Rao R
J Registry Manag; 2014; 41(1):24-30. PubMed ID: 24893185
[TBL] [Abstract][Full Text] [Related]
8. Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database.
Stotter A; Bright N; Silcocks PB; Botha JL
BMJ; 2000 Jul; 321(7255):214. PubMed ID: 10903654
[No Abstract] [Full Text] [Related]
9. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.
Coebergh JW; van den Hurk C; Louwman M; Comber H; Rosso S; Zanetti R; Sacchetto L; Storm H; van Veen EB; Siesling S; van den Eijnden-van Raaij J
Eur J Cancer; 2015 Jun; 51(9):1050-63. PubMed ID: 25934439
[TBL] [Abstract][Full Text] [Related]
10. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
[TBL] [Abstract][Full Text] [Related]
11. Quality control of data in a large-scale cancer register program.
Haenszel W; Lourie WI
Methods Inf Med; 1966 Apr; 5(2):67-74. PubMed ID: 21203654
[No Abstract] [Full Text] [Related]
12. The quest for population-level cancer recurrence data; current deficiencies and targets for improvement.
In H; Simon CA; Phillips JL; Posner MC; Ko CY; Winchester DP
J Surg Oncol; 2015 May; 111(6):657-62. PubMed ID: 25690414
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer data collection for surgical audit.
Woods WG; Earlam RJ
Ann R Coll Surg Engl; 1991 Nov; 73(6):364-71; discussion 372. PubMed ID: 1759766
[TBL] [Abstract][Full Text] [Related]
14. The reliability of Cancer Registry records.
Gulliford MC; Bell J; Bourne HM; Petruckevitch A
Br J Cancer; 1993 Apr; 67(4):819-21. PubMed ID: 8471441
[TBL] [Abstract][Full Text] [Related]
15. The potential and limitations of data from population-based state cancer registries.
Izquierdo JN; Schoenbach VJ
Am J Public Health; 2000 May; 90(5):695-8. PubMed ID: 10800415
[TBL] [Abstract][Full Text] [Related]
16. Congenital anomaly surveillance in England--ascertainment deficiencies in the national system.
Boyd PA; Armstrong B; Dolk H; Botting B; Pattenden S; Abramsky L; Rankin J; Vrijheid M; Wellesley D
BMJ; 2005 Jan; 330(7481):27. PubMed ID: 15561730
[TBL] [Abstract][Full Text] [Related]
17. Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe).
Häggström C; Liedberg F; Hagberg O; Aljabery F; Ströck V; Hosseini A; Gårdmark T; Sherif A; Malmström PU; Garmo H; Jahnson S; Holmberg L
BMJ Open; 2017 Sep; 7(9):e016606. PubMed ID: 28963292
[TBL] [Abstract][Full Text] [Related]
18. National and international variation in the registration of bladder cancer.
Crow P; Ritchie AW
BJU Int; 2003 Oct; 92(6):563-6. PubMed ID: 14511034
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Urothelial Bladder Cancer Survival.
Radkiewicz C; Edgren G; Johansson ALV; Jahnson S; Häggström C; Akre O; Lambe M; Dickman PW
Clin Genitourin Cancer; 2020 Feb; 18(1):26-34.e6. PubMed ID: 31787542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
